最新ニュース Procure Space ETF (NASDAQ:UFO)

Industrials

Communication Services

Technology

Other

Procure Asset Management

The fund invests, under normal circumstances, at least 80% of its net assets in companies of the underlying index that receive at least 50% of their revenues or profits from space-related businesses. The underlying index is designed to serve as an equity benchmark for a globally traded portfolio of companies that are engaged in space-related business, such as those utilizing satellite technology. The fund is non-diversified.

Echostar Corp

Iridium Satellite Llc

Garminltd.

Globalstar Inc

Trimble Inc.

Mda Ltd.

Eutelsat Sa

Sky Perfect Jsat Holdings Inc

Rocket Lab Usa Inc

Viasat Inc

Sirius Xm Radio

Intuitive Machines Inc A

Planet Labs PBC

Procure Space ETF

UFO Gaming

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="4" rowspan="1">2025&nbsp;EPS Guidance Reconciliation</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated EPS on a GAAP basis</td>
<td colspan="1" rowspan="1">$5.71</td>
<td colspan="1" rowspan="1">to</td>
<td colspan="1" rowspan="1">$5.91</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mark-to-market impact of commodity &nbsp; hedging activities</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.03)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sale of AEP OnSite Partners</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.02</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Impact of Ohio Legislation</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.05</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating EPS Guidance</td>
<td colspan="1" rowspan="1">$5.75</td>
<td colspan="1" rowspan="1">to</td>
<td colspan="1" rowspan="1">$5.95</td>
</tr>
</tbody>
</table>
</figure>

News

Guidance

American Electric Power Sees FY2025 GAAP EPS $5.71-$5.91 vs $5.88 Est

Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) lowers FY2025 sales outlook from $818.00 million-$826.00 million to $808.00 million-$816.00 million vs $821.98 million estimate.

OFIX

Orthofix Medical Lowers FY2025 Sales Guidance from $818.00M-$826.00M to $808.00M-$816.00M vs $821.98M Est

Telesat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSAT#NASDAQ">TSAT</a>) lowers FY2025 sales outlook from $285.21 million-$299.30 million to $282.13 million-$296.06 million vs $416.20 million estimate.

TSAT

Telesat Lowers FY2025 Sales Guidance from $285.21M-$299.30M to $282.13M-$296.06M vs $416.20M Est

Needham analyst Charles Shi reiterates Ichor Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICHR#NASDAQ">ICHR</a>) from Hold to Hold.

Reiteration

Analyst Ratings

ICHR

Needham Reiterates Hold on Ichor Holdingsto Hold

Acquisition will equip merchants globally with powerful tools to grow in-store sales and profitability across every channel they operate&nbsp;
<ul>
<li>DoorDash announces acquisition of SevenRooms to enhance its Commerce Platform with omnichannel tools for restaurants and hospitality businesses.</li>
<li>The combination will help merchants grow in-store sales, strengthen customer relationships, and boost profitability by integrating SevenRooms's best-in-class CRM and guest experience tools into the DoorDash Commerce Platform.</li>
<li>SevenRooms will continue its mission to empower restaurants and hospitality operators to deliver exceptional guest experiences, while gaining access to DoorDash's scale, resources, and global reach.</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fdoordash.com%2F&amp;esheet=54249600&amp;newsitemid=20250506217842&amp;lan=en-US&amp;anchor=DoorDash&amp;index=1&amp;md5=b0cb6c4166efb0bf580084289028b1c0">DoorDash</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>), a leading global platform for local commerce, today announced it has reached an agreement to acquire <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fsevenrooms.com%2F&amp;esheet=54249600&amp;newsitemid=20250506217842&amp;lan=en-US&amp;anchor=SevenRooms&amp;index=2&amp;md5=f67d9ab308682abdf489c4973690774a">SevenRooms</a>, a New York City-based software company and a global leader in hospitality technology. The move marks a significant expansion of DoorDash's Commerce Platform capabilities, equipping merchants globally with new tools to grow in-store and delivery sales, build stronger customer relationships, and increase profitability. The acquisition is expected to close during the second half of 2025, subject to customary closing conditions and regulatory approvals.

DASH

DoorDash Agrees To Acquire SevenRooms, Terms Not Disclosed; Deal Expected To Close In H2 of 2025

Fresenius Medical Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) expects FY 2025 revenue to grow by a low single-digit percentage.

Fresenius Medical Care expects FY 2025 revenue to grow by a low single-digit percentage.

American Electric Power Affirms FY25 Adj EPS Guidance of $5.75-$5.95 vs $5.87 Est

Rosenblatt analyst Hans Mosesmann maintains Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) with a Buy and maintains $72 price target.

Price Target

LSCC

Rosenblatt Maintains Buy on Lattice Semiconductor, Maintains $72 Price Target

Coloplast (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLPBY#OTC">CLPBY</a>) reported quarterly earnings of $4.34 per share which missed the analyst consensus estimate of $5.08 by 14.57 percent. This is a 5325 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $6.93 billion which missed the analyst consensus estimate of $6.98 billion by 0.77 percent. This is a 622.53 percent increase over sales of $959.13 million the same period last year.

Earnings

Earnings Misses

CLPBY

Coloplast Q2 Adj. EPS $4.34 Misses $5.08 Estimate, Sales $6.93B Miss $6.98B Estimate

Neuronetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 50 percent. This is a 22.22 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $31.98 million which beat the analyst consensus estimate of $29.07 million by 10.00 percent. This is a 83.59 percent increase over sales of $17.42 million the same period last year.

Earnings Beats

STIM

Neuronetics Q1 EPS $(0.21) Misses $(0.14) Estimate, Sales $31.98M Beat $29.07M Estimate

HLNE

Hamilton Lane Announced The Launch Of The Hamilton Lane Venture Capital And Growth Fund Available To Accredited U.S. Investor Clients

NOVT

Novanta Sees Q2 Adj EPS $0.68-$0.78 vs $0.75 Est; Sees Sales $230.000M-$240.000M vs $240.74M Est

Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) sees Q2 sales of $100.000 million-$110.000 million vs $95.07 million analyst estimate.

SHLS

Shoals Technologies Gr Sees Q2 Sales $100.000M-$110.000M vs $95.07M Est

Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) affirms FY2025 sales outlook from $410.00 million-$450.00 million to $410.00 million-$450.00 million vs $426.46 million estimate.

Shoals Technologies Gr Affirms FY2025 Sales Guidance of $410.00M-$450.00M vs $426.46M Est

Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses
&nbsp;Leading private markets investment firm Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors.
HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what the firm believes to be a high-quality portfolio. The Fund aims to deliver strong returns by investing in disruptive technologies and innovative companies, while leveraging Hamilton Lane's deep expertise in private markets co-investments and secondaries to access compelling deal flow. Structured as an evergreen vehicle, the portfolio is diversified across vintage year, transaction type, manager, strategy and geography.
With a focus on innovation, diversification and institutional-quality assets, the Fund seeks to address common barriers to entry in this dynamic space. It aims to provide investors with upfront capital deployment, flexible liquidity options and exposure to curated opportunities alongside what Hamilton Lane believes are top-tier managers.

Hamilton Lane Announces Launch Of U.S. Venture Capital And Growth Evergreen Fund

With regard to the second quarter, TreeHouse Foods expects the following:
<ul>
<li>Second quarter adjusted net sales are expected in a range of $785 to $800 million, which represents approximately flat growth year-over-year at the mid-point. Organic volume and mix are expected to decline mid-single digits, driven primarily by continued margin management actions and the griddle product recall. Pricing is expected to provide an approximately 1% benefit. &nbsp;</li>
<li>Second quarter adjusted EBITDA is expected in a range of $61 to $71 million, which reflects the shift of $6 million of spend into Q2 from Q1.</li>
</ul>

Treehouse Foods Q2 Adj. Sales Outlook $785.000M-$800.000M vs $785.69M Est

GNPX

Genprex Announced It Has Entered Into An Exclusive Patent License Agreement With Uthealth Houston Granting Genprex Exclusivity And Commercial Rights Relating To Its Lead Drug Candidate, Reqorsa Gene Therapy (Quaratusugene Ozeplasmid) For The Potential Treatment Of Glioblastoma

Telesat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSAT#NASDAQ">TSAT</a>) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.70) by 7.14 percent. This is a 6.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $81.33 million which beat the analyst consensus estimate of $74.64 million by 8.96 percent. This is a 27.96 percent decrease over sales of $112.90 million the same period last year.

Telesat Q1 GAAP EPS $(0.75) Misses $(0.70) Estimate, Sales $81.33M Beat $74.64M Estimate

Financial Outlook
The Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of certain incontinence assets, as follows:
<ul>
<li>Net revenue of $3.18 billion to $3.32 billion, from $3.22 billion to $3.36 billion</li>
<li>Adjusted EBITDA of $665 million to $705 million, from $670 million to $710 million</li>
<li>Free cash flow of $180 million to $220 million, unchanged</li>
</ul>

AHCO

AdaptHealth Lowers FY2025 Sales Guidance From $3.22B-$3.36B To $3.18B-$3.32B Vs $3.27B Est; Sees Adjusted EBITDA Of $665M To $705M (Prior $670M To $710M)

Rosenblatt analyst Kevin Cassidy maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral and maintains $42 price target.

Comments

Procure Space ETF

ニュース

最新ニュース Procure Space ETF (NASDAQ:UFO)

ニュース

パートナーシップ

ベンジンガ・グローバル